For example, Boehringer Ingelheim has dropped the price of its asthma medication Atrovent HFA by 35%. In 2023, the German drugmaker, along with its rivals, such as AbbVie (ABBV), GSK (GSK), and ...
The inhalers affected by this price cap include: - Atrovent HFA (ipratropium bromide HFA) inhalation aerosol - Combivent ...